Quote | Voyageur Pharmaceuticals Ltd. (TSXVC:VM:CC)
Last: | $0.10 |
---|---|
Change Percent: | -9.09% |
Open: | $0.11 |
Close: | $0.10 |
High: | $0.11 |
Low: | $0.1 |
Volume: | 27,000 |
Last Trade Date Time: | 05/06/2022 04:56:44 pm |
News | Voyageur Pharmaceuticals Ltd. (TSXVC:VM:CC)
--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce that the company and Rain Cage Carbon are advancing their collaboration following the first commercial creation of a V@C60 endohedral fullerene or Vanadium atom inside a C60 molecule....
(TheNewswire) Calgary, Alberta, Canada, June 11, 2024 – TheNewswire – Voyageur Pharmaceuticals Ltd . (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") announces that in an innovative endeavor, Voyageur and Rain Cage Carbon Inc. ("Rain Cage") are fo...
Message Board Posts | Voyageur Pharmaceuticals Ltd. (TSXVC:VM:CC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Voyageur Pharmaceuticals Ltd. Company Name:
VM:CC Stock Symbol:
TSXVC Market:
Voyageur Pharmaceuticals Ltd. Website:
--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce that the company and Rain Cage Carbon are advancing their collaboration following the first commercial creation of a V@C60 endohedral fullerene or Vanadium atom inside a C60 molecule....
(TheNewswire) Calgary, Alberta, Canada, June 11, 2024 – TheNewswire – Voyageur Pharmaceuticals Ltd . (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") announces that in an innovative endeavor, Voyageur and Rain Cage Carbon Inc. ("Rain Cage") are fo...
--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce a significant milestone for the company with the signing of its first sales contract valued at USD $1.9 million. The contract spans a three-year term and involves a distribution partn...